Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation
Satoshi Kaito(National Cancer Centre Japan), Kazuteru Ohashi(Tokyo Metropolitan Komagome Hospital), Naoyuki Uchida(Toranomon Hospital), Yuta Katayama(Karolinska University Hospital), Konan Hara(University of Arizona), Takuro Kuriyama(Hamanomachi Hospital), Junichi Mukae(Tokyo Metropolitan Komagome Hospital), Kazuhiro Ikegame(Hyogo Medical University), Ayumi Taguchi(Daiichi-Sankyo (Japan)), Tetsuya Nishida(Nagoya University), Yoshiko Atsuta(The Japanese Data Center for Hematopoietic Cell Transplantation), Junya Kanda(Kyoto University), Y. Nakajima(University of Nottingham), Masao Ogata(Oita University), Takahiro Fukuda(Takarazuka City Hospital), Takashi Toya(Tokyo Metropolitan Komagome Hospital), Yukiyasu Ozawa(Kyoto first Red Cross hospital), Masatsugu Tanaka(Kanagawa Prefectural Hospital Organization)
Cited by 29
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434